Federated Hermes’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Federated Hermes’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-547,433	Closed	-$3.65M	–	2250
2023 Q3	$3.65M	Sell	547,433 -18,318	-3%	-$152K	0.01%	781
2023 Q2	$5.13M	Buy	+565,751	New	+$4.99M	0.01%	688
2022 Q4	–	Sell	-308	Closed	-$2K	–	2307
2022 Q3	$2K	Buy	+308	New	+$2.62K	﹤0.01%	1995

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Federated Hermes's PNT Position: Q4 2023 in Review

Federated Hermes sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 547,433 shares — an estimated $3.65M sold.

Federated Hermes first reported a position in PNT in Q3 2022 and held it in 3 quarters. The position peaked at $5.13M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Federated Hermes reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Federated Hermes sold 547,433 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.65M.
Federated Hermes first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Federated Hermes's POINT Biopharma Global Inc. Common Stock position peaked at $5.13M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.